|Seok-Bae Oh||Chief Financial Officer and Managing Director||N/A||N/A||1971|
|Mr. Won-Gyun Kwon||Sr. MD & Director||N/A||N/A||1954|
|Mr. Ho-Chan Hwang||CEO & Director||N/A||N/A||1958|
HansBiomed Corporation develops, produces, and sells medical materials and ingredients in South Korea and internationally. It offers bone and skin transplant tissue for dentistry, orthopedic/neurosurgery, and skin burn applications; and silicone polymer products, such as BellaGel breast implants, and ScarClinic silicone gel sheet for scar prevention and treatment, as well as forehead, malar, nasal, paranasal, chin, temple, and nostril facial implants. The company also provides medical devices, including Mint Lift, a non-surgical thread for face lifting; and Lion HT/HN, a hair transplanter body/needle. In addition, it offers bio technology products, such as self-skin cell treatment agents and pharmacological agent impregnated bone fillers. The company was formerly known as Hans Medical Corp. and changed its name to HansBiomed Corporation in June 2000. HansBiomed Corporation was founded in 1993 and is based in Seoul, South Korea.
HansBiomed Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.